I-Stem

I-Stem is the largest French laboratory dedicated to human pluripotent stem cells, established in 2005 through a collaboration between Inserm and AFM-Telethon. The institute's focus lies in exploring the therapeutic potential of human pluripotent stem cells for rare genetic diseases. Its research is primarily concentrated on two main areas - cell therapy, which intends to replace lost or diseased cells with those of the same characteristics produced from pluripotent stem cells, and pharmacology, involving the screening of compounds with therapeutic potential based on molecular mechanisms associated with diseases. Currently, I-Stem is working on around a dozen genetic diseases affecting various organs. Moreover, it provides training, technology support, and hosts researchers interested in other diseases annually. The institute's unique positioning within the biotechnology, health care, and marketing industries makes it a compelling entity for investors seeking opportunities in groundbreaking medical research and biotechnological advancements. While the specific details regarding the latest investment and participating investors are not available, I-Stem offers a promising prospect for venture capitalists looking to contribute to the field of rare disease treatment and human pluripotent stem cell research.